Next 10 |
2024-07-02 13:15:22 ET More on S&P 500 Index: Earnings Bar Lowered As Q2 Reports Begin Growth Versus Disinflation Rate Cut By The Fed: Here Is What To Expect For Your Portfolio Citi says the S&P 500 has more upside in H2 and spotlights sectors it pref...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
2024-06-20 21:56:16 ET Summary Baron Capital's 13F stock portfolio value decreased slightly this quarter to $37.52B. Top five stakes include Tesla Motors, Gartner Inc, Arch Capital Group, CoStar Group, and MSCI Inc, totaling ~27% of the portfolio. Stake increases in Red Rock R...
2024-06-04 16:12:36 ET Summary Medpace Holdings is a US-based clinical research organization that is well-positioned to benefit from increased demand due to geopolitical risks affecting Chinese firms. Medpace stands out among its peers due to its growth orientation, competitive ma...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...
2024-05-31 07:00:07 ET David Windley from Jefferies issued a price target of $390.00 for ICLR on 2024-05-31 05:48:00. The adjusted price target was set to $390.00. At the time of the announcement, ICLR was trading at $322.92. The overall price target consensus is at $265...
2024-05-30 15:36:03 ET More on S&P 500 Index: The Markets Are Bracing For The April PCE Report Running Bulls Need No Thinking Is The Glass Half Full Or Half Empty? Nasdaq, S&P, Dow fall on Salesforce drag, mixed signals from Q1 GDP revision Bu...
Highlights Accelerating mid-term financial outlook supported by positive market environment and strengthened, scaled offering. Continued focus on innovation to drive improved outcomes and efficiency in trial delivery. Updated 2024 financial outlook to incorporate positive impact o...
2024-05-24 15:00:53 ET More on the markets S&P 500: It Is All About Liquidity SPY: Time To Be Contrarian And Underweight SPY ETF: Momentum Is In The Cards Stocks have more room to run - Invesco's Kristina Hooper Big bear Mike Wilson changes tune a...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will hold an Investor Day which will take place on Thursday, May 30, 2024 in New York City, starting at 10am ET. The event will include presentations from members of ICO...
News, Short Squeeze, Breakout and More Instantly...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...
2024-05-31 07:00:07 ET David Windley from Jefferies issued a price target of $390.00 for ICLR on 2024-05-31 05:48:00. The adjusted price target was set to $390.00. At the time of the announcement, ICLR was trading at $322.92. The overall price target consensus is at $265...